Aptevo names Mary Janatpour chief scientific officer

PUBT · 1d ago
Aptevo names Mary Janatpour chief scientific officer
  • Aptevo named Mary J. Janatpour as senior vice president, chief scientific officer in its second-quarter 2026 update.
  • Janatpour brings more than 25 years of oncology R&D leadership across large biopharma groups and emerging biotech companies.
  • She will lead research and preclinical development, supporting clinical priorities, the multispecific pipeline, radiopharmaceutical collaboration, and trispecific solid-tumor programs.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptevo Therapeutics Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608140805ACCESSWRNAPR_____1207149) on August 14, 2026, and is solely responsible for the information contained therein.